240 related articles for article (PubMed ID: 30826616)
1. High-throughput screening and chemotype-enrichment analysis of ToxCast phase II chemicals evaluated for human sodium-iodide symporter (NIS) inhibition.
Wang J; Hallinger DR; Murr AS; Buckalew AR; Lougee RR; Richard AM; Laws SC; Stoker TE
Environ Int; 2019 May; 126():377-386. PubMed ID: 30826616
[TBL] [Abstract][Full Text] [Related]
2. Expanded high-throughput screening and chemotype-enrichment analysis of the phase II: e1k ToxCast library for human sodium-iodide symporter (NIS) inhibition.
Wang J; Richard AM; Murr AS; Buckalew AR; Lougee RR; Shobair M; Hallinger DR; Laws SC; Stoker TE
Arch Toxicol; 2021 May; 95(5):1723-1737. PubMed ID: 33656581
[TBL] [Abstract][Full Text] [Related]
3. Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).
Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Stoker TE; Laws SC
Toxicol In Vitro; 2017 Apr; 40():66-78. PubMed ID: 27979590
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of potential sodium-iodide symporter (NIS) inhibitors using a secondary Fischer rat thyroid follicular cell (FRTL-5) radioactive iodide uptake (RAIU) assay.
Buckalew AR; Wang J; Murr AS; Deisenroth C; Stewart WM; Stoker TE; Laws SC
Arch Toxicol; 2020 Mar; 94(3):873-885. PubMed ID: 32065294
[TBL] [Abstract][Full Text] [Related]
5. High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter.
Stoker TE; Wang J; Murr AS; Bailey JR; Buckalew AR
Chem Res Toxicol; 2023 Mar; 36(3):380-389. PubMed ID: 36821091
[TBL] [Abstract][Full Text] [Related]
6. High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library.
Wang J; Hallinger DR; Murr AS; Buckalew AR; Simmons SO; Laws SC; Stoker TE
Environ Sci Technol; 2018 May; 52(9):5417-5426. PubMed ID: 29611697
[TBL] [Abstract][Full Text] [Related]
7. Development of a non-radioactive screening assay to detect chemicals disrupting the human sodium iodide symporter activity.
Dong H; Atlas E; Wade MG
Toxicol In Vitro; 2019 Jun; 57():39-47. PubMed ID: 30738889
[TBL] [Abstract][Full Text] [Related]
8. Effect of triclosan, triclocarban, 2,2',4,4'-tetrabromodiphenyl ether, and bisphenol A on the iodide uptake, thyroid peroxidase activity, and expression of genes involved in thyroid hormone synthesis.
Wu Y; Beland FA; Fang JL
Toxicol In Vitro; 2016 Apr; 32():310-9. PubMed ID: 26827900
[TBL] [Abstract][Full Text] [Related]
9. Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.
Paul Friedman K; Watt ED; Hornung MW; Hedge JM; Judson RS; Crofton KM; Houck KA; Simmons SO
Toxicol Sci; 2016 May; 151(1):160-80. PubMed ID: 26884060
[TBL] [Abstract][Full Text] [Related]
10. Perfluorooctane sulfonic acid, a persistent organic pollutant, inhibits iodide accumulation by thyroid follicular cells in vitro.
Conti A; Strazzeri C; Rhoden KJ
Mol Cell Endocrinol; 2020 Sep; 515():110922. PubMed ID: 32621861
[TBL] [Abstract][Full Text] [Related]
11. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
[No Abstract] [Full Text] [Related]
12. Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals.
Rotroff DM; Dix DJ; Houck KA; Knudsen TB; Martin MT; McLaurin KW; Reif DM; Crofton KM; Singh AV; Xia M; Huang R; Judson RS
Environ Health Perspect; 2013 Jan; 121(1):7-14. PubMed ID: 23052129
[TBL] [Abstract][Full Text] [Related]
13. Development of an In Vitro Human Thyroid Microtissue Model for Chemical Screening.
Deisenroth C; Soldatow VY; Ford J; Stewart W; Brinkman C; LeCluyse EL; MacMillan DK; Thomas RS
Toxicol Sci; 2020 Mar; 174(1):63-78. PubMed ID: 31808822
[TBL] [Abstract][Full Text] [Related]
14. Revision of the affinity constant for perchlorate binding to the sodium-iodide symporter based on in vitro and human in vivo data.
Schlosser PM
J Appl Toxicol; 2016 Dec; 36(12):1531-1535. PubMed ID: 27177048
[TBL] [Abstract][Full Text] [Related]
15. MEK signaling modulates sodium iodide symporter at multiple levels and in a paradoxical manner.
Vadysirisack DD; Venkateswaran A; Zhang Z; Jhiang SM
Endocr Relat Cancer; 2007 Jun; 14(2):421-32. PubMed ID: 17639055
[TBL] [Abstract][Full Text] [Related]
16. Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.
Browne P; Judson RS; Casey WM; Kleinstreuer NC; Thomas RS
Environ Sci Technol; 2015 Jul; 49(14):8804-14. PubMed ID: 26066997
[TBL] [Abstract][Full Text] [Related]
17. Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells.
Liu YY; Zhang X; Ringel MD; Jhiang SM
Endocr Relat Cancer; 2012 Jun; 19(3):291-304. PubMed ID: 22355179
[TBL] [Abstract][Full Text] [Related]
18. Perchlorate transport and inhibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L.
Cianchetta S; di Bernardo J; Romeo G; Rhoden KJ
Toxicol Appl Pharmacol; 2010 Mar; 243(3):372-80. PubMed ID: 20005887
[TBL] [Abstract][Full Text] [Related]
19. Screening the ToxCast phase II libraries for alterations in network function using cortical neurons grown on multi-well microelectrode array (mwMEA) plates.
Strickland JD; Martin MT; Richard AM; Houck KA; Shafer TJ
Arch Toxicol; 2018 Jan; 92(1):487-500. PubMed ID: 28766123
[TBL] [Abstract][Full Text] [Related]
20. Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases.
Olker JH; Korte JJ; Denny JS; Hartig PC; Cardon MC; Knutsen CN; Kent PM; Christensen JP; Degitz SJ; Hornung MW
Toxicol Sci; 2019 Apr; 168(2):430-442. PubMed ID: 30561685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
